Skip to main content

Peer Review reports

From: Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab

Original Submission
13 Nov 2022 Submitted Original manuscript
19 Jun 2023 Reviewed Reviewer Report
27 Jun 2023 Reviewed Reviewer Report
10 Jul 2023 Author responded Author comments - Etsuro Hatano
Resubmission - Version 2
10 Jul 2023 Submitted Manuscript version 2
Publishing
14 Aug 2023 Editorially accepted
21 Aug 2023 Article published 10.1186/s12885-023-11302-6

You can find further information about peer review here.

Back to article page